BUY Biocon Ltd — Ashish Chaturmohta, JM Financial
byAshish Chaturmohta, JM FinancialHorizon: 1–3 months15 Jul 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Biocon's subsidiary received a positive opinion from EMA's CHMP for its Pertuzumab biosimilar (Pebrilzo) for HER2-positive breast cancer treatment. This is the first biosimilar to receive such recomme
BSE · Company Update·21 Sept · yesterday
Biocon's biosimilar Pertuzumab has received a positive recommendation from the EMA's CHMP under a new tailored clinical approach, marking a significant regulatory milestone.
NSE · Press Release·21 Sept · yesterday
3 other SEBI-registered advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·19 Sept · 3d ago
Biocon shares rise 3% after Rs 638-crore block deal; Active Pine likely seller
NewsEt-Markets·9 Sept · 2w ago
Biocon shares gain nearly 3% after equity worth ₹630 crore changes hands in block deal
NewsCnbc-Tv18·9 Sept · 2w ago
Biocon Block Deal: Active Pine likely to sell 1.66 crore shares at ₹385 per share
NewsCnbc-Tv18·8 Sept · 2w ago
Biocon Block Deal: True North Likely To Sell Rs 640-Crore Stake, Sources Say
NewsNdtv-Profit·8 Sept · 2w ago
Buy, Sell Or Hold: IndiGo, Maruti Suzuki, Biocon, LIC, Hindustan Copper, Bharat Dynamics — Ask Profit
NewsNdtv-Profit·2 Sept · 3w ago
Buy, Sell Or Hold: Mahindra & Mahindra, Coforge, TVS Motor, Biocon And Divi's Labs — Ask Profit
NewsNdtv-Profit·30 Aug · 3w ago
MACD below its signal line — bearish momentum
Technicals · macd·22 Sept · today
US Drug Tariff: 15 Pharma Stocks Likely to Be Impacted by Trump’s New Tariff Plan
NewsGoogle News·16 Sept · 6d ago
Biocon shares: Active Pine may divest up to 1% equity worth Rs 638 crore via block deal
NewsEt-Markets·8 Sept · 2w ago
3 advisors have active long-term SELL calls on this stock
Advisor consensus · adjacent horizon·15 Jul · 2mo ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.